Modulation in Pharmacokinetic Properties of Mirtazapine and Citalopram During Contemporaneous Therapy With Ritonavir

Journal of Pharmacology and Toxicology - United States
doi 10.3923/jpt.2012.29.37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Alert

Related search

Modulation of Brain Activation During Executive Functioning in Autism With Citalopram

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2019English

Iatrogenic Cushing Syndrome and Adrenal Insufficiency During Concomitant Therapy With Ritonavir and Fluticasone

SpringerPlus
Multidisciplinary
2015English

Changes in Weight and Glucose Tolerance During Treatment With Mirtazapine

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Applying Pharmacokinetic/Pharmacodynamic Principles for Optimizing Antimicrobial Therapy During Continuous Renal Replacement Therapy

Anaesthesiology Intensive Therapy
MedicineCritical CareAnesthesiologyPain MedicineIntensive Care Medicine
2017English

Risk of Suicide During Treatment With Venlafaxine, Citalopram, Fluoxetine, and Dothiepin: Retrospective Cohort Study

BMJ
2006English

Ceftriaxone Pharmacokinetic Properties During Continuous Venovenous Haemofiltration Using an in Vitro Model

Critical Care
Critical CareIntensive Care Medicine
2008English

Use of Mirtazapine in Children and Adolescents

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy